Artia Global Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-160,000	Closed	-$2.16M	–	41
2025 Q1	$2.16M	Buy	160,000 +60,000	+60%	+$809K	0.55%	20
2024 Q4	$1.92M	Buy	+100,000	New	+$1.92M	0.69%	22